Transforming growth factor beta (TGF-beta) exerts an inhibitory effect on the growth of most epithelial cell types, and the loss of responsiveness to this growth inhibition has been implicated in the development of a variety of human cancers. The genetic alteration of TGF-beta receptors is known to
Expression of transforming-growth-factor (TGF)-β receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-β1
✍ Scribed by Ester Piek; Ulrica Westermark; Marianne Kastemar; Carl-Henrik Heldin; E. Joop van Zoelen; Monica Nistér; Peter Ten Dijke
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- French
- Weight
- 268 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
A panel of 6 human glioma cell lines was examined for TGF-1 responsiveness. U-178 MG and U-251 MG AgCl1 were significantly inhibited by TGF-1, while U-343 MGa 31L and U-343 MGa 35L were potently stimulated to proliferate. TGF-1 induced endogenous PAI-1 protein synthesis, Smad binding element/(CAGA) 12 -luciferase-reporter activity, as well as mRNA expression of Smad6 and Smad7 in all gliomas. Interestingly, TGF-1 differentially stimulated or inhibited the expression of TR-I and TR-II mRNA in the gliomas. Affinity cross-linking studies using 125 I-TGF-1 revealed that the gliomas expressed TGF--type-I(TR-I) and -type-II(TR-II) receptors, although binding to TR-II in U-343 MGa 31L and U-251 MG AgCl1 was low to undetectable. Smad2 protein was abundantly present in U-178 MG, U-343 MG, and U-343 MGa 35L, while Smad3 was readily detectable in U-178 MG, U-343 MG, U-343 MGa 35L and U-251 MG AgCl1. In all gliomas, TGF-1 induced phosphorylation of Smad2. The level to which TGF-1 could activate the pathway leading to induction of the (CAGA) 12 -luciferase reporter seemed to correlate to the expression levels of TGF- receptors, Smad3 and Smad4 proteins. However, despite the plethora of data regarding TGF-1 signalling in the different glioma cell lines, the mechanism underlying the differential growth effects mediated by TGF-1 is still unclear. The results suggest that a complex balance between several components in the TGF- signalling pathway controls glioma responsiveness to TGF-1, and extend reports indicating that distinct signal transduction pathways are involved in growth inhibition and other cellular responses.
📜 SIMILAR VOLUMES
Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi
The epidermal growth factor (EGF) receptor mediates the effects of both EGF and transforming growth factor alpha (TGFalpha). Recent data suggested that EGF acts as a partial agonist/antagonist in hepatocytes, TGFalpha exerting a larger maximal stimulation of DNA synthesis than EGF. To further study
The bone morphogenetic protein (BMP)-2 is a potent osteoinductive signal, inducing bone formation in vivo and osteoblast differentiation from non-osseous cells in vitro. The runt domain-related protein Cbfa1/PEBP2␣A/ AML-3 is a critical component of bone formation in vivo and transcriptional regulat